文献速递糖尿病肥胖与代谢综合征

代谢状态决定利拉鲁肽增强胰岛素分泌的脑与胰岛直接效应

Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion.
PubMed 文献 · Diabetologia · 2026-06-25

研究探讨利拉鲁肽在不同代谢状态下作用机制的异质性。利用不同HbA1c供体胰岛及小鼠模型,发现利拉鲁肽在糖耐量受损供体胰岛中增强葡萄糖刺激的胰岛素分泌,健康状态依赖下丘脑伸展细胞介导的脑通路,代谢功能障碍时直接胰岛效应恢复,晚期代谢疾病则通过不依赖胰岛素的机制维持降糖疗效。

要点

  • 利拉鲁肽的作用机制随代谢状态变化:健康时依赖脑通路,糖耐量受损时直接胰岛效应显现。
  • 2型糖尿病供体胰岛GLP-1R mRNA水平随HbA1c升高而进行性下降。
  • 晚期代谢疾病中利拉鲁肽通过抑制肝糖异生和增强外周葡萄糖摄取维持降糖疗效。

核心结论

  • 利拉鲁肽通过互补的、代谢状态依赖的通路发挥作用:健康条件下以伸展细胞介导的脑作用为主,糖耐量受损时出现直接胰岛效应,不依赖胰岛素的机制在代谢状态间维持疗效。

研究设计与样本

  • 使用不同代谢状态供体的人胰岛进行动态灌流和静态孵育评估葡萄糖刺激的胰岛素分泌;在112例供体胰岛中按HbA1c分层测量GLP-1R mRNA水平。
  • 机制研究使用伸展细胞特异性GLP-1R敲低小鼠和表达肉毒毒素B的小鼠以区分中枢与外周通路,并进行口服葡萄糖耐量试验、丙酮酸耐量试验和正电子发射断层扫描。

主要发现

  • 利拉鲁肽(25 nmol/l)在糖耐量受损供体(n=7,p=0.021)中增强葡萄糖刺激的胰岛素分泌,在血糖正常供体(n=7)中无效应,尽管GLP-1(7-36)反应性保留。
  • 2型糖尿病胰岛中GLP-1R mRNA水平随HbA1c升高而进行性下降(p=0.015,血糖正常[n=48] vs 2型糖尿病[n=10])。
  • 在普通饮食喂养小鼠中,利拉鲁肽的胰岛素刺激效应需要伸展细胞介导的下丘脑通路,GLP-1RTanycyteKD小鼠中反应消失。
  • 在12周高脂饮食诱导的代谢功能障碍中,直接胰岛反应性恢复且不依赖伸展细胞功能。
  • 在27周高脂饮食诱导的晚期代谢疾病中,离体胰岛反应性保留但体内胰岛素增强效应丧失,揭示涉及抑制肝糖异生和增强外周葡萄糖摄取的不依赖胰岛素的降糖机制。

临床怎么用

  • 利拉鲁肽的疗效机制随代谢状态变化,提示可根据个体代谢特征匹配其主要作用机制以优化2型糖尿病治疗。
  • 在糖耐量受损阶段,利拉鲁肽的直接胰岛效应可能更突出;在晚期代谢疾病中,不依赖胰岛素的降糖机制维持疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist for type 2 diabetes and obesity management, shows variable patient responses. We investigated the metabolic state-dependent mechanisms underlying this heterogeneity and how liraglutide's mode of action shifts across stages of metabolic dysfunction. METHODS: We employed human pancreatic islets from donors across metabolic states (normoglycaemic [HbA1c <42 mmol/l (<6.0%)], glucose intolerance [HbA1c 42-47 mmol/l (6.0-6.4%)] and type 2 diabetes [HbA1c ≥48 mmol/l (≥6.5%)]) using dynamic perifusion and static incubation techniques to assess glucose-stimulated insulin secretion. GLP-1R mRNA levels were measured in 112 donor islets stratified by HbA1c. Mechanistic investigations used tanycyte-specific GLP-1R knockdown (GLP-1RTanycyteKD) mice and botulinum toxin B-expressing (iBot) mice to distinguish between central and peripheral pathways. Oral glucose tolerance tests, pyruvate tolerance tests and positron emission tomography were performed to assess in vivo metabolic effects. RESULTS: Liraglutide (25 nmol/l) enhanced glucose-stimulated insulin secretion specifically in donors with glucose intolerance (n=7, p=0.021), with no effect in normoglycaemic islets (n=7), despite preserved GLP-1 (7-36) responsiveness. In type 2 diabetes islets, GLP-1R mRNA levels progressively decreased with rising HbA1c (p=0.015, normoglycaemic [n=48] vs type 2 diabetes [n=10]). In chow-fed mice, liraglutide's insulin-stimulating effects required tanycyte-mediated hypothalamic access, as demonstrated by abolished responses in GLP-1RTanycyteKD mice. However, during metabolic dysfunction (a 12-week high-fat diet), direct islet responsiveness was restored independent of tanycyte function. Advanced metabolic disease (a 27-week high-fat diet) maintained islet responsiveness ex vivo while losing in vivo insulin enhancement, revealing insulin-independent glucose-lowering mechanisms involving hepatic gluconeogenesis suppression and enhanced peripheral glucose uptake. CONCLUSIONS/INTERPRETATION: Liraglutide operates through complementary, metabolic state-dependent pathways: tanycyte-mediated brain actions predominate in healthy conditions, direct islet effects emerge during glucose intolerance and insulin-independent mechanisms maintain efficacy across metabolic states. This mechanistic framework enables potential patient stratification in type 2 diabetes therapy, suggesting that matching liraglutide's predominant mechanism to individual metabolic profiles could optimise treatment outcomes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Saponaro C, Imbernon M, Louvet I, et al. Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion. Diabetologia. 2026. PMID: 42350670. doi:10.1007/s00125-026-06779-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。